431 related articles for article (PubMed ID: 2164219)
1. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.
Linsley PS; Clark EA; Ledbetter JA
Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5031-5. PubMed ID: 2164219
[TBL] [Abstract][Full Text] [Related]
2. The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.
Koulova L; Clark EA; Shu G; Dupont B
J Exp Med; 1991 Mar; 173(3):759-62. PubMed ID: 1847724
[TBL] [Abstract][Full Text] [Related]
3. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2.
Gimmi CD; Freeman GJ; Gribben JG; Sugita K; Freedman AS; Morimoto C; Nadler LM
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6575-9. PubMed ID: 1650475
[TBL] [Abstract][Full Text] [Related]
4. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
[TBL] [Abstract][Full Text] [Related]
5. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal.
Ranheim EA; Kipps TJ
J Exp Med; 1993 Apr; 177(4):925-35. PubMed ID: 7681471
[TBL] [Abstract][Full Text] [Related]
6. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.
Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL
J Exp Med; 1992 Feb; 175(2):353-60. PubMed ID: 1370679
[TBL] [Abstract][Full Text] [Related]
7. Discordant expression of CD28 ligands, BB-1, and B7 on keratinocytes in vitro and psoriatic cells in vivo.
Nickoloff BJ; Mitra RS; Lee K; Turka LA; Green J; Thompson C; Shimizu Y
Am J Pathol; 1993 Apr; 142(4):1029-40. PubMed ID: 7682758
[TBL] [Abstract][Full Text] [Related]
8. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.
Linsley PS; Brady W; Grosmaire L; Aruffo A; Damle NK; Ledbetter JA
J Exp Med; 1991 Mar; 173(3):721-30. PubMed ID: 1847722
[TBL] [Abstract][Full Text] [Related]
9. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line.
Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL
J Immunol; 1992 Aug; 149(4):1115-23. PubMed ID: 1380031
[TBL] [Abstract][Full Text] [Related]
10. CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling.
Linsley PS; Bradshaw J; Urnes M; Grosmaire L; Ledbetter JA
J Immunol; 1993 Apr; 150(8 Pt 1):3161-9. PubMed ID: 7682233
[TBL] [Abstract][Full Text] [Related]
11. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M
Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232
[TBL] [Abstract][Full Text] [Related]
12. Direct helper T cell-induced B cell differentiation involves interaction between T cell antigen CD28 and B cell activation antigen B7.
Damle NK; Linsley PS; Ledbetter JA
Eur J Immunol; 1991 May; 21(5):1277-82. PubMed ID: 1645270
[TBL] [Abstract][Full Text] [Related]
13. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.
Tan P; Anasetti C; Hansen JA; Melrose J; Brunvand M; Bradshaw J; Ledbetter JA; Linsley PS
J Exp Med; 1993 Jan; 177(1):165-73. PubMed ID: 7678111
[TBL] [Abstract][Full Text] [Related]
14. Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway.
Freedman AS; Freeman GJ; Rhynhart K; Nadler LM
Cell Immunol; 1991 Oct; 137(2):429-37. PubMed ID: 1716521
[TBL] [Abstract][Full Text] [Related]
15. Functional expression of B7/BB1 on activated T lymphocytes.
Azuma M; Yssel H; Phillips JH; Spits H; Lanier LL
J Exp Med; 1993 Mar; 177(3):845-50. PubMed ID: 7679711
[TBL] [Abstract][Full Text] [Related]
16. Antibody and B7/BB1-mediated ligation of the CD28 receptor induces tyrosine phosphorylation in human T cells.
Vandenberghe P; Freeman GJ; Nadler LM; Fletcher MC; Kamoun M; Turka LA; Ledbetter JA; Thompson CB; June CH
J Exp Med; 1992 Apr; 175(4):951-60. PubMed ID: 1372649
[TBL] [Abstract][Full Text] [Related]
17. Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
Galea-Lauri J; Darling D; Gan SU; Krivochtchapov L; Kuiper M; Gäken J; Souberbielle B; Farzaneh F
J Immunol; 1999 Jul; 163(1):62-70. PubMed ID: 10384100
[TBL] [Abstract][Full Text] [Related]
18. The BB1 monoclonal antibody recognizes both cell surface CD74 (MHC class II-associated invariant chain) as well as B7-1 (CD80), resolving the question regarding a third CD28/CTLA-4 counterreceptor.
Freeman GJ; Cardoso AA; Boussiotis VA; Anumanthan A; Groves RW; Kupper TS; Clark EA; Nadler LM
J Immunol; 1998 Sep; 161(6):2708-15. PubMed ID: 9743327
[TBL] [Abstract][Full Text] [Related]
19. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo.
Turka LA; Linsley PS; Lin H; Brady W; Leiden JM; Wei RQ; Gibson ML; Zheng XG; Myrdal S; Gordon D
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):11102-5. PubMed ID: 1332070
[TBL] [Abstract][Full Text] [Related]
20. T lymphocytes in skin lesions of psoriasis and mycosis fungoides express B7-1: a ligand for CD28.
Nickoloff BJ; Nestle FO; Zheng XG; Turka LA
Blood; 1994 May; 83(9):2580-6. PubMed ID: 7513205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
